Anne T. Truesdale
Target (United States)(US)Cellular Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer Treatment and Pharmacology, Cancer Mechanisms and Therapy, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)(2004)1,108 cited
- → Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor(1994)571 cited
- → Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity(2007)512 cited
- → Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor(2008)342 cited
- → Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs(1993)138 cited
- → Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors(2008)83 cited
- → Agouti Antagonism of Melanocortin Binding and Action in the B16F10 Murine Melanoma Cell Line(1995)77 cited
- → Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib(2008)70 cited
- → Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases(2006)58 cited
- → 4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors(2004)49 cited